pipamperone has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies
pipamperone: RN given refers to parent cpd; structure
pipamperone : A member of the class of bipiperidines that is 1,4'-bipiperidine which is substituted at the 1' and 4' positions by 4-(p-fluorophenyl)-4-oxobutyl and carboxamide groups, respectively. A first generation antipsychotic, its properties are generally similar to those of haloperidol.
Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pipamperone is a frequently prescribed antipsychotic in children and adolescents in the Netherlands, Belgium, and Germany." | 1.56 | Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents. ( Bahmany, S; de Winter, BCM; Dieleman, GC; Dierckx, B; Egberts, KM; Gerlach, M; Hillegers, MHJ; Kloosterboer, SM; Koch, BCP; Kouijzer, MEJ; Reichart, CG; van Daalen, E; van Gelder, T, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kloosterboer, SM | 1 |
| Egberts, KM | 1 |
| de Winter, BCM | 1 |
| van Gelder, T | 1 |
| Gerlach, M | 1 |
| Hillegers, MHJ | 1 |
| Dieleman, GC | 1 |
| Bahmany, S | 1 |
| Reichart, CG | 1 |
| van Daalen, E | 1 |
| Kouijzer, MEJ | 1 |
| Dierckx, B | 1 |
| Koch, BCP | 1 |
1 other study available for pipamperone and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and Adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Butyrophenones; | 2020 |